Figure 2 (Sevelamer Figure1)
Sevelamer Carbonate Tablet
Product Images NDC 42571-378
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 42571-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 3 (Sevelamer Figure2)
This appears to be a graph or chart displaying the reduction in serum phosphorus levels (measured in mg/dL) for a medication called "Sevelamer Hydrochloride". The chart shows the percentage of patients who experienced either worsening or improvement of their serum phosphorus levels compared to baseline levels, with an active control group also included. It is unclear what the values on the x and y axes represent, as well as the significance of the text "with Reduction >X". More context would be needed to interpret the information fully.*
Figure 4 (Sevelamer Figure3)
Sevelamer-labl.jpg (Sevelamer Labl)
This is a medication called Sevelamer carbonate, contained in tablets of 800mg each. The dosage should be determined by the package insert. The tablets should be stored at controlled room temperature and protected from moisture. They come in a bottle of 30 tablets and are manufactured in India by Micro Labs USA, Inc. This medication is only available with a prescription.*
Structure (Sevelamer Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
